Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity.
about
Autochthonous Hepatitis E Virus Infection in Europe: A Matter of Concern for Public Health?Molecular Biology and Infection of Hepatitis E VirusNon-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004 - 2006Hepatitis E virus: animal reservoirs and zoonotic riskTransmission, diagnosis, and management of hepatitis E: an updateProfile of acute infectious markers in sporadic hepatitis E.Synthetic rabbit-human antibody conjugate as a control in immunoassays for immunoglobulin M specific to hepatitis E virus.Hepatitis E virus seroprevalence among blood donors in southwest Switzerland.Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia.Diagnosis of HEV infection by serological and real-time PCR assays: a study on acute non-A-C hepatitis collected from 2004 to 2010 in Italy.Epidemiology and associated risk factors of hepatitis e virus infection in plateau state, Nigeria.An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European populationHospital-based surveillance for viral hemorrhagic fevers and hepatitides in Ghana.Epidemiology of zoonotic hepatitis E: a community-based surveillance study in a rural population in ChinaDetection of serum antibodies to hepatitis E virus in domestic pigs in Italy using a recombinant swine HEV capsid proteinHepatitis E virus antibodies in blood donors, France.Hepatitis E virus infection among solid organ transplant recipients, the NetherlandsRisk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, EgyptCharacterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.Seroprevalence of hepatitis E virus differs in Dutch and first generation migrant populations in Amsterdam, the Netherlands: a cross-sectional study.Diagnostic Performance of Five Assays for Anti-Hepatitis E Virus IgG and IgM in a Large Cohort StudyGuillain-Barré syndrome following hepatitis E.Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae.Development of a novel enzyme-linked immunosorbent assay to detect anti-IgG against swine hepatitis E virus.Hepatitis E virus infection.Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review.Hepatitis E virus: what transplant physicians should know.Diagnosis of hepatitis E.Hepatitis e virus: current concepts and future perspectives.Hepatitis E: latest developments in knowledge.Epidemiology of HEV infection during pregnancy in Benin.Production and characterization of a Brazilian candidate antigen for Hepatitis E Virus genotype 3 diagnosis.Valuable antibody detection method for classifying hepatitis E virus genotypes.Laboratory Diagnosis of HEV Infection.Genetic Evolution of Hepatitis E Virus.Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections.Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey.Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area.Coexistence of IgM antihepatitis A virus and IgM antihepatitis E virus in acute viral hepatitis: a prospective, multicentre study in Korea.Prevalence of specific antibody to hepatitis E virus in the general population of the community of Madrid, Spain.
P2860
Q26996093-0D8BD7C8-DF90-4E8B-975F-9DD8EA5A353CQ28066101-B0619708-69B6-4694-A3E0-A5D3E1608B95Q33332382-699F799E-15C5-490B-BFA1-D66947B3D2BFQ33429348-1ACF14A0-6A46-488D-8831-7F363D7280A9Q33734018-CAAD57A1-E199-4E43-8657-DEBFE0C0D782Q33735801-DA889200-66A1-4948-9D65-8A52451C436AQ33898371-94469EE2-4938-461D-9296-0643303318EDQ33942000-742BE483-5CAA-447F-BBD8-BC33934CD6F0Q34123677-F285D591-46CD-494A-A7F3-FDE3BBEF51E5Q34306554-D575DB9D-9470-4336-ABEB-682B573BA088Q34607030-3DD01A69-F489-4E5B-8FA3-235DA4C104BCQ34717939-2A2960BD-19F3-44BC-B01C-4F33DD583A51Q34999873-00EF1039-8EB3-4A5D-920A-39313321899BQ35086897-FA6E7962-27BD-41A2-B7B6-FA0956EBB912Q35189231-2263264C-E819-49F3-8725-F1DD7C31E1E1Q35849075-C550699A-AFE2-4E37-AFC4-344037DB7D5CQ35979542-6A87C7EE-0575-4D15-B694-28680F25E647Q36102477-001BB227-468A-4867-9D70-AC7D76384AA4Q36171812-955D0322-7E4E-4383-ADA8-B4F7E72C8FB4Q36185969-4505BC5F-E3FB-47D9-A99B-707173D466B2Q36620859-A64419F7-F07E-4CBD-B528-D5D43F859A20Q37160576-F105727C-538D-4135-AB8F-0BAB8D26B6D9Q37374797-F5BD1854-2A58-43C7-9165-9B642317A34CQ37453374-B5CD3537-1A69-4839-A5B7-5FF44C9DA0B2Q37544935-5C37AE29-ED81-4E98-8862-03F65E359496Q37608678-014CA536-BEEF-438E-963F-85269FCC20A1Q38006813-848F6E70-89EF-4BE0-97AB-21514BCD5F1BQ38048600-D18904EF-35B6-4959-9B1B-F113B5F49530Q38192527-565E74B2-9C23-4A06-A0D7-19FC0B448C5FQ38839954-8798B34D-E224-4FF1-87BC-7ED0A8CF6637Q38966704-DCB2DC7A-FFA8-448A-B0E5-8A0071316ADFQ40035451-EE3EA31E-74BB-4D44-A5F3-7D8A65695F58Q40079762-AD2267C5-187F-4840-8801-4069E492541BQ40507410-BABC2330-DB0F-4D8A-8A1C-3685C8121681Q40507442-30E183DD-19E1-41C4-91C4-7FAC107736D1Q42016304-6709EFFB-CC2B-402C-AC87-FD53F3846CC2Q42218953-D2008C71-F9AC-4176-82D1-2C415F4F569FQ42244866-F8997752-75A2-47F7-B0FE-5E1BF780B59CQ43427533-A06D81AB-D580-49D2-891F-9F16F511A482Q45361626-F1442817-0D06-4286-9DEE-7C3231922ECD
P2860
Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Use of serological assays for ...... n a setting of low endemicity.
@ast
Use of serological assays for ...... n a setting of low endemicity.
@en
type
label
Use of serological assays for ...... n a setting of low endemicity.
@ast
Use of serological assays for ...... n a setting of low endemicity.
@en
prefLabel
Use of serological assays for ...... n a setting of low endemicity.
@ast
Use of serological assays for ...... n a setting of low endemicity.
@en
P2860
P50
P356
P1476
Use of serological assays for ...... n a setting of low endemicity.
@en
P2093
P2860
P304
P356
10.1128/CVI.00231-06
P577
2007-03-14T00:00:00Z